Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Metabolic Abnormalities Predict Heart Disease

By HospiMedica staff writers
Posted on 25 Jul 2003
A study has found that a more accurate predictor of heart disease than cholesterol levels is metabolic syndrome, a cluster of metabolic abnormalities. More...
The finding was reported in the July 15, 2003, issue of Circulation.

Under new guidelines, patients are considered to have metabolic syndrome if they have three or more of the following five conditions: abdominal obesity, high levels of trigyclerides, low levels of high-density lipoprotein (HDL), high blood sugar levels, and high blood pressure.

Researchers used data from a coronary study of 6,447 men in Scotland. All had moderately elevated levels of low-density lipoprotein (LDL). Using the new guidelines, 26% of the men had the metabolic syndrome, with almost twice the risk of heart disease and more than three times the risk of developing diabetes, compared to men without abnormalities. The risk increased as the number of abnormalities rose. Men with four or five abnormalities had almost four times the risk of heart disease and 24.5 times the risk of diabetes. The diabetes finding was important, since there are currently fewer predictive measures to identify people at risk of developing the disease.

"This is the first prospective study to show that the new criteria predict excess risk for both coronary heart disease and diabetes,” said lead author Naveed Sattar, M.D., a consultant in clinical biochemistry at the Glasgow Royal Infirmary (Scotland). The researchers also looked at another variable, C-reactive protein (CRP), a marker of inflammation that has been linked to heart disease. They found that CRP levels were also higher in men with the metabolic syndrome than in those without it.




Related Links:
Glasgow Royal Infirmary

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.